Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia, Lymphocytic, Chronic, B-Cell 21Congenital Abnormalities 21Leukemia 20Lymphoma, Follicular 19Lymphoma, B-Cell, Marginal Zone 19Breast Neoplasms 19Multiple Myeloma 17Lymphoma, Mantle-Cell 17Myelodysplastic Syndromes 15Lymphoma, Non-Hodgkin 15Lymphoma, Large B-Cell, Diffuse 15Myeloproliferative Disorders 13Lymphoma, Large-Cell, Immunoblastic 13Lymphoma 13Burkitt Lymphoma 13Blast Crisis 13Lymphoma, T-Cell, Cutaneous 12Leukemia, Myelomonocytic, Chronic 12Leukemia, Myeloid, Accelerated Phase 12Sezary Syndrome 11Mycosis Fungoides 11Leukemia, Myeloid, Chronic-Phase 11Neoplasms, Plasma Cell 10Hodgkin Disease 10Waldenstrom Macroglobulinemia 9Primary Myelofibrosis 9Pdgfra-Associated Chronic Eosinophilic Leukemia 8Leukemia, Neutrophilic, Chronic 8

Interventions

Carboplatin 88pembrolizumab 85Paclitaxel 71Cyclophosphamide 63Capecitabine 38Doxorubicin 37Taxes 29130-nm albumin-bound paclitaxel 29Cisplatin 25Albumin-Bound Paclitaxel 22Epirubicin 21Drug Therapy 21Docetaxel 20sacituzumab govitecan 19olaparib 19camrelizumab 18atezolizumab 18Gemcitabine 17eribulin 16durvalumab 16Bevacizumab 16Radiotherapy 15toripalimab 14Specimen Handling 14Biopsy 13Everolimus 12Magnetic Resonance Spectroscopy 11apatinib 10Nivolumab 10talazoparib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Triple Negative Breast Neoplasms × Flow Cytometry × Clear all
NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡